{
    "2019-03-09": [
        [
            {
                "time": "",
                "original_text": "【民生医药|公司深度】华兰生物：血制品景气度提升，四价流感疫苗空间百亿元，成长空间充足",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制品",
                        "景气度提升",
                        "四价流感疫苗",
                        "百亿元空间",
                        "成长空间充足"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}